Table 1 Patient characteristics
Characteristics | |
|---|---|
Mean age, years (range) | 64 (range 46–79) |
| Â | No. of patients (%) |
Gender | |
Men | 14 (74%) |
Women | 5 (26%) |
Diagnosis | |
Multiple myeloma | 18 (95%) |
Amyloidosis | 1 (5%) |
Peripheral Neuropathy (PN) | |
Grade 2 | 13 (68%) |
Grade 3 | 6 (32%) |
PN Treatment | Â |
Pregabalin | 11 (58%) |
Gabapentin | 6 (32%) |
None | 2 (10%) |
Pain Management* | Â |
Hydrocodone | 4 (21%) |
Oxycodone | 3 (16%) |
Morphine | 1 (5%) |
Hydromorphone + bupivacaine (pump) | 1 (5%) |
Prior Therapy | Â |
Bortezomib | 16 (84%) |
Thalidomide | 3 (16%) |
Dose of Prior Therapy | Â |
Bortezomib, mg (range) | 31.7 (10.5-64) |
Thalidomide, g (range) | 84.7 (8.4-163) |
No. Months Since Last Dose (range) | 9.8 (0.75-41.5) |